PIQ 1.54% 66.0¢ proteomics international laboratories ltd

Ann: Clinical utility study shows benefit of PromarkerD testing, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 33 Posts.
    lightbulb Created with Sketch. 3
    This is massive!!! Clearly a win whereby PromarkerD will become a common tool for physicians to use in determining treatment for Diabetes patients.
 
watchlist Created with Sketch. Add PIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.